Keyphrases
Administration Error
18%
Alectinib
50%
All-small-molecule
10%
Ammonium Acetate
10%
Anticancer Treatment
12%
Apixaban
50%
Bolus Injection
37%
Breast Cancer Resistance Protein
12%
Brigatinib
50%
C-18
10%
Chromatographic Separation
10%
Clinical Practice
10%
Cytochrome P450 3A4 (CYP3A4)
12%
Direct Oral Anticoagulants
25%
Drug Interactions
50%
EDTA Plasma
50%
Electrospray Ionization Interface
10%
Formic Acid
10%
Freezing Temperature
10%
Gradient Elution
10%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
50%
Improvement Strategies
50%
K2EDTA
50%
Lean Six Sigma
50%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
10%
Lorlatinib
50%
Low Molecular Weight Heparin
50%
Mass Spectrometer
10%
Mass Spectrometry Methods
10%
Medication Administration Errors
50%
Methanol
10%
MS Method
50%
Non-small Cell Lung Cancer (NSCLC)
60%
Older Patients
12%
Oncogene-driven
10%
P-glycoprotein (P-gp)
12%
Parenteral Medication
50%
Plasma Concentration
37%
Potential Risk
50%
Pralsetinib
50%
Prescribing Errors
50%
Prophylactic Treatment
12%
Protein-protein Interaction
12%
Quad
10%
Quality Control
10%
Risk of Harm
50%
Room Temperature
10%
Selpercatinib
50%
Small Molecule Inhibitors
40%
Thrombophlebitis
12%
INIS
acetates
12%
administration
53%
anticoagulants
25%
breasts
12%
cancer
62%
carbon 18
12%
carbon 20
25%
chromatography
12%
concentration
37%
control
10%
detection
12%
doses
32%
drugs
53%
edta
50%
errors
100%
formic acid
12%
freezing
12%
glycoproteins
12%
heparin
50%
hospitals
11%
hplc
50%
humans
50%
induction
12%
inhibition
12%
injection
21%
interactions
50%
interfaces
12%
interventions
21%
ionization
12%
kidneys
7%
liquids
12%
lung cells
62%
mass spectrometers
12%
mass spectrometry
12%
methanol
12%
molecular weight
50%
molecules
50%
monitoring
12%
patients
36%
plasma
87%
proteins
12%
quality control
12%
range
25%
risks
61%
temperature range 0273-0400 k
12%
therapy
16%
validation
50%
values
12%
water
12%
weight
7%
